Influence of MRI Follow-Up on Treatment Decisions during Standard Concomitant and Adjuvant Chemotherapy in Patients with Glioblastoma: Is Less More?

SIMPLE SUMMARY: Glioblastomas are brain tumors with a poor prognosis, and early tumor progression occurs often. Therefore, patients are closely monitored with regular MRI scans, usually at 2–3 month intervals. However, there is no evidence for this strategy, and it is not known if patients benefit f...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dijken, Bart R. J., Doff, Annerieke R., Enting, Roelien H., van Laar, Peter Jan, Jeltema, Hanne-Rinck, Dierckx, Rudi A. J. O., van der Hoorn, Anouk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605145/
https://www.ncbi.nlm.nih.gov/pubmed/37894340
http://dx.doi.org/10.3390/cancers15204973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605145/
https://www.ncbi.nlm.nih.gov/pubmed/37894340
http://dx.doi.org/10.3390/cancers15204973

Ejemplares similares